Cancellation of state registration. Magnesium sulfate

April 3rd, 2018
Active substances:
ICD-10:
IV.E50-E64.E61.2    Magnesium deficiency
VI.G40-G47.G40    Epilepsy
IX.I10-I15.I10    Essential [primary] hypertension
IX.I30-I52.I47.2    Ventricular tachycardia
XI.K55-K63.K59.0    Constipation
XI.K80-K87.K81.1    Chronic cholecystitis
XI.K80-K87.K81.0    Acute cholecystitis
XI.K80-K87.K82.8    Other specified diseases of the gallbladder
XI.K80-K87.K83.0    Cholangitis
XV.O10-O16.O15    Eclampsia
XV.O60-O75.O60    Premature birth
XVIII.R25-R29.R25.2    Cramp and spasm
XVIII.R30-R39.R33    Retention of urine
XIX.T51-T65.T56    Toxicity of metals
XXI.Z40-Z54.Z51.4    Preparatory procedures for subsequent treatment, not elsewhere classified
Magnesium sulfate, magnesium deficiency, constipation, treatment of constipation, poisoning with salts of heavy metals, bowel cleansing before diagnostic manipulation

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On circulation of medicines", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N001466 / 01 from August 29, 2008 issued by OJSC "Pharmaceutical Factory of St. Petersburg", Russia):

Magnesium sulfate (trade name of the drug)

Magnesium sulfate (international non-proprietary or chemical name of the drug)

powder for solution for oral administration (dosage form, dosage)

OAO "Pharmaceutical Factory of St. Petersburg", Russia 193144, St. Petersburg, ul. Moiseenko, d. 24-а (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the owner of the registration certificate of OJSC "Pharmaceutical Factory of St. Petersburg", Russia, a statement on the abolition of the state registration of the medicinal product.